The DOI matches its Crossref record; 267 of the 267 references it cites were found in a registry or an index.
Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?
Open accessAbstract
Traumatic brain injury (TBI) is the leading cause of death and disability in young adults. Survivors of TBI frequently suffer from long‐term personality changes and deficits in cognitive and motor performance, urgently calling for novel pharmacological treatment options. To date, all clinical trials evaluating neuroprotective compounds have failed in demonstrating clinical efficacy in cohorts of severely injured TBI patients. The purpose of the present review is to describe the utility of animal models of TBI for preclinical evaluation of pharmacological compounds. No single animal model can adequately mimic all aspects of human TBI owing to the heterogeneity of clinical TBI. To successfully develop compounds for clinical TBI, a thorough evaluation in several TBI models and injury severities is crucial. Additionally, brain pharmacokinetics and the time window must be carefully evaluated. Although the search for a single‐compound, ‘silver bullet’ therapy is ongoing, a combination of drugs targeting various aspects of neuroprotection, neuroinflammation and regeneration may be needed. In summary, finding drugs and prove clinical efficacy in TBI is a major challenge ahead for the research community and the drug industry. For a successful translation of basic science knowledge to the clinic to occur we believe that a further refinement of animal models and functional outcome methods is important. In the clinical setting, improved patient classification, more homogenous patient cohorts in clinical trials, standardized treatment strategies, improved central nervous system drug delivery systems and monitoring of target drug levels and drug effects is warranted. LINKED ARTICLES This article is part of a themed issue on Translational Neuropharmacology. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.164.issue‐4
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghajar, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02689-1 · Cited by 2,238
Moderate and severe traumatic brain injury in adults
Maas, A. I., Stocchetti, N., & Bullock, R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70164-9 · Cited by 2,123
The Role of Excitatory Amino Acids and NMDA Receptors in Traumatic Brain Injury
Faden, A. I., Demediuk, P., Panter, S. S., & Vink, R. (1989) · Science · doi:10.1126/science.2567056 · Cited by 1,508
A new model of diffuse brain injury in rats: Part I: Pathophysiology and biomechanics
Marmarou, A., Foda, M. A. A.-E., Brink, W. V. D., Campbell, J., Kita, H., & Demetriadou, K. (1994) · Journal of Neurosurgery · doi:10.3171/jns.1994.80.2.0291 · Cited by 1,229
A systematic review of brain injury epidemiology in Europe
Tagliaferri, F., Compagnone, C., Korsic, M., Servadei, F., & Kraus, J. (2006) · Acta Neurochirurgica · doi:10.1007/s00701-005-0651-y · Cited by 1,223
Classification of traumatic brain injury for targeted therapies
Saatman, K. E., Duhaime, A.-C., Bullock, R., Maas, A. I. R., Valadka, A., & Manley, G. T. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2008.0586 · Cited by 1,141 · cited 3×
“On the clinical side the ongoing international effort to come up with a novel classification system for TBI patients is widely appreciated (see Saatman et al., 2008) and may enable selection of more homogenous patient cohorts in future clinical trials.”
A controlled cortical impact model of traumatic brain injury in the rat
Edward Dixon, C., Clifton, G. L., Lighthall, J. W., Yaghmai, A. A., & Hayes, R. L. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90104-8 · Cited by 1,141
Katayama, Y., Becker, D. P., Tamura, T., & Hovda, D. A. (1990) · Journal of Neurosurgery · doi:10.3171/jns.1990.73.6.0889 · Cited by 1,091
A fluid percussion model of experimental brain injury in the rat
Dixon, C. E., Lyeth, B. G., Povlishock, J. T., Findling, R. L., Hamm, R. J., Marmarou, A., Young, H. F., & Hayes, R. L. (1987) · Journal of Neurosurgery · doi:10.3171/jns.1987.67.1.0110 · Cited by 1,034
Traumatic Brain Injury: A Disease Process, Not an Event
Masel, B. E., & DeWitt, D. S. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1358 · Cited by 955
Cited by
Animal models of traumatic brain injury
Xiong, Y., Mahmood, A., & Chopp, M. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3407 · Cited by 1,408
The far-reaching scope of neuroinflammation after traumatic brain injury
Simon, D. W., McGeachy, M. J., Bayır, H., Clark, R. S. B., Loane, D. J., & Kochanek, P. M. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.13 · Cited by 1,190
Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift
Jassam, Y. N., Izzy, S., Whalen, M., McGavern, D. B., & El Khoury, J. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.010 · Cited by 799
Traumatic Brain Injury: Current Treatment Strategies and Future Endeavors
Galgano, M., Toshkezi, G., Qiu, X., Russell, T., Chin, L., & Zhao, L.-R. (2017) · Cell Transplantation · doi:10.1177/0963689717714102 · Cited by 582
Ren, Z., Iliff, J. J., Yang, L., Yang, J., Chen, X., Chen, M. J., Giese, R. N., Wang, B., Shi, X., & Nedergaard, M. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.30 · Cited by 311
Metadata
- Authors
- Marklund, N., & Hillered, L.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-10
- Volume
- 164
- Issue
- 4
- Pages
- 1207-1229
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1600183911
- Cited by
- 252
- References
- 267
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here? https://app.cochat.ai/papers/10.1111/j.1476-5381.2010.01163.x
- The paper
- Marklund, N., & Hillered, L. (2011). Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here? British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2010.01163.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.